Nivolumab News

15 Sept 20269:06 pm

Healthcare15 Sept 2026 · 9:06 pm9:06 pm

Dr. Reddy's Laboratories Introduces Nivolumab Biosimilar NIVORZ for Cancer Care in India

Dr. Reddy's Laboratories has launched NIVORZ, a biosimilar of nivolumab, in India to enhance immune response against various cancers. Approved by the DCGI for t

3 Sept 20262:58 am

Science and Technology3 Sept 2026 · 2:58 am2:58 am

Create visual

Biomarkers Predict Improved Outcomes for Lung Cancer Patients on Perioperative Nivolumab

Exploratory analyses from the phase III CheckMate 77T study indicate that specific biomarkers, including pre-surgical clearance of circulating tumour DNA, predi

13 Aug 202612:32 am

Science13 Aug 2026 · 12:32 am12:32 am

Create visual

Biomarkers identified for nivolumab benefit in resectable non-small cell lung cancer

Research from the CheckMate 77T trial has identified potential predictive biomarkers for the benefit of perioperative nivolumab therapy in resectable non-small

Nivolumab News

#Nivolumab

Dr. Reddy's Laboratories Introduces Nivolumab Biosimilar NIVORZ for Cancer Care in India

Biomarkers Predict Improved Outcomes for Lung Cancer Patients on Perioperative Nivolumab

Biomarkers identified for nivolumab benefit in resectable non-small cell lung cancer

Discover Faster

Stay Organized

Create Effortlessly

Newsroom FAQs

Drive Greater Impact